abstract |
The invention relates to a pharmaceutical composition combining a selective progesterone-receptor modulator (SPRM), such as ulipristal acetate, and one or more non-steroidal anti-inflammatory drugs, said composition being used, in particular, in a regular contraception method, or as an emergency or on-demand form of contraception. |